US: +1 617 696-7335 | EU: +353 1 685 4800|
Home/Company News

<< Back to News & Events

  • IonOptix Phase II SBIR Grant

IonOptix Awarded Phase II SBIR Support


Following the successful completion of our Phase I goals of prototyping, testing, and developing a new high-throughput cardiac myocyte acquisition system, IonOptix has been awarded Phase II funding from the Small Business Innovation Research (SBIR) grant

IonOptix Awarded Phase II SBIR Support2019-11-12T11:50:28-05:00